Search

Displaying results 7061 - 7070 of 10000 in total
  1. Drug

    3,4-Dihydroxybenzoic Acid

    go.drugbank.com/drugs/DB03946
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    KOS-1584

    go.drugbank.com/drugs/DB05903
    Investigational

    KOS-1584 is a second-generation epothilone. Epothilones are anticancer agents with a taxane-like mechanism of action that have demonstrated activity in taxane-resistant tumors. … KOS-1584 is a second-generation compound with increased potency, favorable tissue distribution, and ease of formulation.

  3. Drug

    Carotuximab

    go.drugbank.com/drugs/DB06322
    Investigational

  4. Drug

    CCX915

    go.drugbank.com/drugs/DB05159
    Experimental

    CCX915 is developed by ChemoCentryx which targets the chemokine receptor CCR2 and is in phase 1 of clinical trial for the treatment of Multiple Sclerosis and Neurologic Disorders. … The CCR2 receptor is thought to be of central importance to inflammatory diseases, such as multiple sclerosis (MS), Type II diabetes and atherosclerosis.

  5. Drug

    V24343

    go.drugbank.com/drugs/DB05201
    Investigational

    The anti-obesity drug, V24343, acts by targeting the CB1 receptor in the brain and suppressing a person's appetite.

  6. Drug

    Daidzein

    go.drugbank.com/drugs/DB13182
    Investigational

    Categories: Topoisomerase II Inhibitors
  7. Drug

    Carbutamide

    go.drugbank.com/drugs/DB13406
    Investigational

    Categories: Drugs Used in Diabetes
  8. Drug

    Lorajmine

    go.drugbank.com/drugs/DB13651
    Experimental

    Categories: Antiarrhythmics, Class I, Antiarrhythmics, Class Ia
  9. Drug

    Phenothrin

    go.drugbank.com/drugs/DB13717
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    Opaganib

    go.drugbank.com/drugs/DB12764
    Investigational

    Opaganib, also known as ABC294640, is a selective [sphingosine kinase-2 (SK2)](https://go.drugbank.com/polypeptides/Q9NRA0) inhibitor that is orally administered. … [L27436] This drug has potential anticancer, anti-inflammatory, and antiviral activities, with potential applications in oncology, inflammation, the gastrointestinal system, and COVID-19.